Clinical Trial

Safety of Dose Escalation in Definitive Hypofractionated Radiation Therapy and Hormone Therapy With SpaceOAR TM for Patients With High - Risk Localized Prostate Cancer (DESAR-H)

Study acronym: DESAR-H
Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
Dose increase after injection of biodegradable material A safety study of high-risk prostate cancer patients who underwent low-fractionation curative radiation therapy and hormone therapy
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-06-11.
Trial Details
NCT Number NCT06461793
Lead Sponsor Samsung Medical Center
Conditions High Risk Prostate Carcinoma
Enrollment 33 participants
Start Date 2023-09-12
Primary Completion 2033-12-31 (estimated)
Study Completion 2033-12-31 (estimated)
Updated on ClinicalTrials.gov 2024-06-21